Randomized Controlled Study Comparing the Efficacy and Tolerance of Bepotastine, a New 2nd Generation Antihistamine, to Fexofenadine, in Symptomatic Relief of Patients With Pruritic Cutaneous Disorders
Journal of Clinical & Experimental Dermatology Research
doi 10.4172/2155-9554.1000466
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
OMICS Publishing Group